5.20.2005
Launched right at E3: brainspeed
>
Here's the wire release that hit right at E3, I thought you might be interested. For now, you can buy brainspeed at brainspeed.com. Got any feedback? Let me know.
LOS ANGELES -(BUSINESS WIRE)-May 19, 2005-Natrol, Inc. (NASDAQ: NTOL - News), a nationally recognized manufacturer of health supplements, announced the launch of its Natrol brainSpeed (TM)line of three cognitive health supplements that include a patent-pending formula -- the brainSpeed Blend(TM). Targeting the cholinergic system - the key to cognitive speed - the brainSpeed blend was tested clinically to help promote mental agility, maintain memory and improve speed.
In another major innovation, Natrol brainSpeed also represents the first time a nutritional supplement provides a tool for consumers to verify results on an individual basis. Through the use of the brainSpeedOmeter(TM) online test powered in partnership with Cognitive Labs, consumers have the ability to establish a baseline for their mental processing speed. When they use the products as recommended and retest themselves, users will be able to measure changes in their own cognitive processing speed. This tool delivers on the product line's promise of providing individual results (www.brainspeed.com).
According to Natrol CEO Elliott Balbert: "We have been developing the Natrol brainSpeed project for 2-1/2 years. This effort included significant investment in research, formula testing and safety testing to lead this emerging category. Not only are vital boomers interested in their mental well-being but so are students, professionals and executives -- even game players and athletes. The brain is the C.P.U. (central processing unit) of our body. It is time the nutraceutical industry delivered a legitimate brain health product from a company that backs it with science, safety and sincerity."
Natrol is departing from its customary strategy of broadly rolling out the product into all its retail stores. The company has selected key marketing partners to deliver the three new items to the consumer. The Natrol brainSpeed line will initially be available at select independent health food stores; at Walgreens, the nation's largest drugstore chain; online at www.drugstore.com; and at select GNC outlets. The company will also be working with the National Senior Olympics, US Chess Federation and key alpha influencers online via the Internet.
About Natrol brainSpeed
The extensive research conducted by the company produced a core blend of five vital nutrients. These nutrients support the processing speed of information through the synapses of the brain. By supporting this key blend with additional nutrients the company was able to key in on three different cognitive fields. They are brainSpeed Attention(TM), brainSpeed Memory(TM) and brainSpeed Perform(TM). Each unique compound targets a different functionality, thereby broadening the line's marketing appeal to a national consumer base from all walks of life.
Founded in 1980, Natrol, Inc. is a diversified nutrition company that manufactures and markets premium branded nutritional products, functional teas and sports fitness products under the Natrol, Laci Le Beau Tea and Prolab Sports Nutrition labels.
Natrol markets more than 500 nutritional products domestically and around the world. For more information visit www.natrol.com.
The statements made in this press release which are not historical facts, including statements regarding expectations for future growth of revenue and profits and trends concerning net sales, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors, the Company's actual results could differ materially from those set forth in the forward-looking statements. Certain factors that might cause Natrol's actual results to differ materially from those set forth in the forward-looking statements include adverse trends in the dietary supplements industry, intense competition, adverse effects of unfavorable publicity regarding particular products or the Company's industry generally, the Company's dependence on the introduction of successful new products, the Company's ability to gain market share and shelf space in each of its distribution channels, the Company experiencing high rates of product returns, and adverse government regulation, as well as those factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2004, and in the Company's other filings with the Securities and Exchange Commission.
(a) These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose,
treat, cure or prevent any disease.
